Spina E - Search Results

1

The effect of clozapine on aggressive behaviour in patients with chronic schizophrenia.

De Domenico P, Di Rosa AE, Dagostino AA, Martino G, Meduri M, Spina E. De Domenico P, et al. Among authors: spina e. Int J Psychiatry Clin Pract. 1999;3(1):49-54. doi: 10.3109/13651509909024759. Int J Psychiatry Clin Pract. 1999. PMID: 24945067

2

Polymorphic debrisoquine oxidation and acute neuroleptic-induced adverse effects.

Spina E, Ancione M, Di Rosa AE, Meduri M, Caputi AP. Spina E, et al. Eur J Clin Pharmacol. 1992;42(3):347-8. doi: 10.1007/BF00266363. Eur J Clin Pharmacol. 1992. PMID: 1349529 No abstract available.

3

Debrisoquine oxidation phenotype and neuroleptic-induced dystonic reactions.

Spina E, Sturiale V, Valvo S, Ancione M, Di Rosa AE, Meduri M, Caputi AP. Spina E, et al. Acta Psychiatr Scand. 1992 Nov;86(5):364-6. doi: 10.1111/j.1600-0447.1992.tb03281.x. Acta Psychiatr Scand. 1992. PMID: 1485526

4

Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients.

Spina E, De Domenico P, Ruello C, Longobardo N, Gitto C, Ancione M, Di Rosa AE, Caputi AP. Spina E, et al. Int Clin Psychopharmacol. 1994 Winter;9(4):281-5. doi: 10.1097/00004850-199400940-00007. Int Clin Psychopharmacol. 1994. PMID: 7868850 Clinical Trial.

5

Iron status in schizophrenic patients with acute neuroleptic-induced dystonic reactions.

Spina E, Ancione M, Di Rosa AE, Artemisia A, Natoli C, Caputi AP. Spina E, et al. Prog Neuropsychopharmacol Biol Psychiatry. 1994 Sep;18(5):891-8. doi: 10.1016/0278-5846(94)90105-8. Prog Neuropsychopharmacol Biol Psychiatry. 1994. PMID: 7972859 Clinical Trial.

6

Prevalence of acute dystonic reactions associated with neuroleptic treatment with and without anticholinergic prophylaxis.

Spina E, Sturiale V, Valvo S, Ancione M, Di Rosa AE, Meduri M, Caputi AP. Spina E, et al. Int Clin Psychopharmacol. 1993 Spring;8(1):21-4. doi: 10.1097/00004850-199300810-00003. Int Clin Psychopharmacol. 1993. PMID: 8097213

7

Epidemiology and pathoetiology of neurological syndromes with hyperthermia.

Di Rosa AE, Morgante L, Spina E, Meduri M. Di Rosa AE, et al. Among authors: spina e. Funct Neurol. 1995 May-Jun;10(3):111-9. Funct Neurol. 1995. PMID: 8557212 Review. No abstract available.

8

Effect of fluoxetine on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenia.

Spina E, Avenoso A, Facciolà G, Fabrazzo M, Monteleone P, Maj M, Perucca E, Caputi AP. Spina E, et al. Int Clin Psychopharmacol. 1998 May;13(3):141-5. doi: 10.1097/00004850-199805000-00009. Int Clin Psychopharmacol. 1998. PMID: 9690983

9

Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.

Spina E, Avenoso A, Facciolà G, Scordo MG, Ancione M, Madia AG, Ventimiglia A, Perucca E. Spina E, et al. Psychopharmacology (Berl). 2000 Jan;148(1):83-9. doi: 10.1007/s002130050028. Psychopharmacology (Berl). 2000. PMID: 10663421

10

Quetiapine versus clozapine: a preliminary report of comparative effects on dopaminergic psychosis in patients with Parkinson's disease.

Morgante L, Epifanio A, Spina E, Di Rosa AE, Zappia M, Basile G, La Spina P, Quattrone A. Morgante L, et al. Among authors: spina e. Neurol Sci. 2002 Sep;23 Suppl 2:S89-90. doi: 10.1007/s100720200084. Neurol Sci. 2002. PMID: 12548358 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

412 results

Search Page

Filters